SCHEMBL6919429

SCHEMBL6919429

CC(NC(=O)c1[nH]nc2c1CCCC2)c1cccc(C(=O)NO)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPK1 P28482 4/20 0.41
LMNA P02545 1/20 0.41
ROCK2 O75116 4/20 0.41
PARP1 P09874 3/20 0.41
ROCK1 Q13464 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HSP90AA1 P07900 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
WDR5 P61964 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPK3 P27361 1/20 0.38
BDKRB1 P46663 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13545871 0.84 ALDH1A1 (0.56) ALDH1A1NPC1RAB9AMAPK1LMNA
SCHEMBL16075533 0.78 POLB (0.43) ALDH1A1MAPK1LMNAROCK2ROCK1
SCHEMBL2438985 0.74 ALDH1A1 (0.48) ALDH1A1MAPK1LMNAROCK2ROCK1
SCHEMBL6918740 0.73 ALDH1A1 (0.47) ALDH1A1NPC1RAB9AMAPK1ROCK2
SCHEMBL6919184 0.72 ALDH1A1 (0.48) ALDH1A1MAPK1ROCK2ROCK1HDAC3
SCHEMBL12279796 0.71 MAPK1 (0.48) ALDH1A1MAPK1LMNAROCK2ROCK1
SCHEMBL6918942 0.71 ALDH1A1 (0.47) ALDH1A1MAPK1LMNAROCK2ROCK1
SCHEMBL6919822 0.70 ALDH1A1 (0.46) ALDH1A1ROCK2ROCK1HDAC6
SCHEMBL2407297 0.70 ALDH1A1 (0.45) ALDH1A1LMNAROCK2ROCK1HDAC6
SCHEMBL12279819 0.70 ALDH1A1 (0.57) ALDH1A1NPC1MAPK1LMNAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 US disclosed
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC10, HDAC1 ALDH1A1 1696/4885NPC1 3704/4885RAB9A 2010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.